Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-12-04

Clinical Trial Update: Sulindac and Tamoxifen in Treating Patients With Desmoid Tumor [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating sulindac and tamoxifen for desmoid tumor has completed with results posted in 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Sulindac (sulindac)
  • Tamoxifen (tamoxifen)

Snippet

Sponsor: Children's Oncology Group | Conditions: Desmoid Tumor | Phase 2 | Status: COMPLETED | Results posted: 2013-12-04